Rosa Argüeso

1.0k total citations
14 papers, 209 citations indexed

About

Rosa Argüeso is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rosa Argüeso has authored 14 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rosa Argüeso's work include Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Rosa Argüeso is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Rosa Argüeso collaborates with scholars based in Spain, Chile and Australia. Rosa Argüeso's co-authors include José Luis Díaz-Díaz, Pedro Mata, Leopoldo Pérez de Isla, Rodrigo Alonso, Francisco Fuentes, Ovidio Muñiz-Grijalvo, Raimundo de Andrés, Juan Francisco Sánchez Muñoz-Torrero, Rafaela Soler and Adriana Saltijeral Cerezo and has published in prestigious journals such as Circulation, European Heart Journal and Atherosclerosis.

In The Last Decade

Rosa Argüeso

12 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa Argüeso Spain	8	136	68	47	36	30	14	209
Pedro Luis Ruíz Sáenz Spain	6	201 1.5×	80 1.2×	48 1.0×	80 2.2×	11 0.4×	10	252
Luis Irigoyen Spain	6	270 2.0×	121 1.8×	45 1.0×	94 2.6×	12 0.4×	9	348
Seyedmohammad Saadatagah United States	9	71 0.5×	28 0.4×	73 1.6×	27 0.8×	5 0.2×	32	209
Stephen Jones Australia	6	265 1.9×	27 0.4×	84 1.8×	36 1.0×	54 1.8×	11	386
Rochelle Thiart South Africa	11	250 1.8×	68 1.0×	35 0.7×	86 2.4×	34 1.1×	23	372
Daisuke Shishikura Australia	10	210 1.5×	22 0.3×	115 2.4×	13 0.4×	69 2.3×	21	301
Yunfei Duan China	11	134 1.0×	25 0.4×	32 0.7×	49 1.4×	53 1.8×	23	331
Benjamin Chevalier France	8	86 0.6×	114 1.7×	33 0.7×	26 0.7×	43 1.4×	28	273
Anne Tybjærg-Hansen Denmark	4	131 1.0×	84 1.2×	42 0.9×	56 1.6×	20 0.7×	6	319

Countries citing papers authored by Rosa Argüeso

Since Specialization

Citations

This map shows the geographic impact of Rosa Argüeso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Argüeso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Argüeso more than expected).

Fields of papers citing papers by Rosa Argüeso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Argüeso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Argüeso. The network helps show where Rosa Argüeso may publish in the future.

Co-authorship network of co-authors of Rosa Argüeso

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Argüeso. A scholar is included among the top collaborators of Rosa Argüeso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Argüeso. Rosa Argüeso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

López‐Alonso, Marta, et al.. (2025). Observance of the Atlantic Diet in a Healthy Population from Galicia (NW Spain): A Comparative Study Using a New Scale-Based Procedure to Assess Adherence. Foods. 14(15). 2614–2614.

Alonso, Rodrigo, José Luis Díaz-Díaz, Francisco Fuentes, et al.. (2024). Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study. Atherosclerosis. 393. 117516–117516. 7 indexed citations

Isla, Leopoldo Pérez de, José Luis Díaz-Díaz, Manuel Jesús Romero-Jiménez, et al.. (2024). Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study. Circulation Cardiovascular Imaging. 17(1). 8 indexed citations

Isla, Leopoldo Pérez de, José Luis Díaz-Díaz, Manuel Jesús Romero-Jiménez, et al.. (2023). Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study. Circulation. 147(19). 1436–1443. 52 indexed citations

Argüeso, Rosa, Juan Pedro‐Botet, Xavier Pintó, et al.. (2023). Prevalencia de dislipemia aterogénica, factores relacionados y grado de control lipídico en la población general de Galicia. Estudio GALIPEMIAS. Clínica e Investigación en Arteriosclerosis. 35(4). 178–184.

Isla, Leopoldo Pérez de, Rodrigo Alonso, Rosa Argüeso, et al.. (2022). Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients. Journal of clinical lipidology. 16(5). 733–736. 4 indexed citations

Alonso, Rodrigo, et al.. (2022). Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?. Current Atherosclerosis Reports. 24(6). 427–434. 12 indexed citations

Alonso, Rodrigo, José Luis Díaz-Díaz, Juan Francisco Sánchez Muñoz-Torrero, et al.. (2022). Persistence to long-term PCSK9 inhibitors treatment and its effectiveness in familial hypercholesterolemia: data from the SAFEHEART study. European Heart Journal. 43(Supplement_2). 1 indexed citations

Alonso, Rodrigo, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, et al.. (2021). Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience. Journal of clinical lipidology. 15(4). 584–592. 11 indexed citations

10.

Alonso, Rodrigo, José Luis Díaz-Díaz, Francisco Arrieta, et al.. (2016). Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry. Journal of clinical lipidology. 10(4). 953–961. 34 indexed citations

11.

Mata, Pedro, Rodrigo Alonso, José Luis Díaz-Díaz, et al.. (2014). Hiperlipidemia familiar combinada: documento de consenso. Atención Primaria. 46(8). 440–446. 15 indexed citations

12.

Mata, Pedro, Rodrigo Alonso, José Luis Díaz-Díaz, et al.. (2014). Hiperlipidemia familiar combinada: documento de consenso. Medicina de Familia SEMERGEN. 40(7). 374–380. 3 indexed citations

13.

Pellat, Fernando Paz, José Cameselle‐Teijeiro, Joaquín Lado‐Abeal, et al.. (2008). Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. European Journal of Endocrinology. 159(5). 623–631. 47 indexed citations

14.

Soler, Rafaela, et al.. (1996). MRI of Mediastinal Parathyroid Cystic Adenoma Causing Hyperparathyroidism. Journal of Computer Assisted Tomography. 20(1). 166–168. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact